Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6453)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yamakado K, Hirota S. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas. World J Gastroenterol 2015; 21(37): 10604-10608 [PMID: 26457020 DOI: 10.3748/wjg.v21.i37.10604] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i37/10604.htm |
| Number | Citing Articles |
| 1 |
Yutaka Yasui, Kaoru Tsuchiya, Masayuki Kurosaki, Takaya Takeguchi, Yuko Takeguchi, Mao Okada, Wan Wang, Yohei Kubota, Tomoyuki Goto, Yasuyuki Komiyama, Mayu Higuchi, Kenta Takaura, Tsuguru Hayashi, Hitomi Takada, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Nobuyuki Enomoto, Yoshiro Himeno, Namiki Izumi. Up‐to‐seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child–Pugh grade deterioration after initial conventional transarterial chemoembolization. Hepatology Research 2018; 48(6): 442 doi: 10.1111/hepr.13048
|
| 2 |
Michele Campigotto, Mauro Giuffrè, Anna Colombo, Alessia Visintin, Alessandro Aversano, Martina Budel, Flora Masutti, Cristiana Abazia, Lory Saveria Crocé. Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature. World Journal of Hepatology 2020; 12(12): 1239-1257 doi: 10.4254/wjh.v12.i12.1239
|
| 3 |
W. Teng, Y.‐C. Hsieh, K.‐W. Lui, W.‐T. Chen, C.‐F. Hung, C.‐H. Huang, Y.‐C. Chen, W.‐J. Jeng, C.‐C. Lin, C.‐Y. Lin, S.‐M. Lin, I.‐S. Sheen. Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization. Journal of Viral Hepatitis 2017; 24(12): 1160 doi: 10.1111/jvh.12745
|
| 4 |
Marie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc. Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on Lenvatinib. Cancers 2021; 13(24): 6310 doi: 10.3390/cancers13246310
|
| 5 |
Jella-Andrea Abraham, Olga Golubnitschaja. Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon?. Personalized Medicine 2016; 13(5): 455 doi: 10.2217/pme-2016-0013
|
| 6 |
Nada El-domiaty, Faouzi Saliba, Eric Vibert, Vincent Karam, Rodolphe Sobesky, Wafaa Ibrahim, Gabriella Pittau, Oriana Ciacio, Chady Salloum, Khaled Amer, Maysaa A. Saeed, Jihan A. Shawky, Antonio Sa Cunha, Olivier Rosmorduc, Daniel Cherqui, René Adam, Didier Samuel. Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome. Transplantation 2021; 105(8): 1778 doi: 10.1097/TP.0000000000003434
|
| 7 |
Yang Yantong, Liu Shan, Chu Zhijie, Zheng Youwei. A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy. European Journal of Surgical Oncology 2018; 44(10): 1595 doi: 10.1016/j.ejso.2018.06.009
|
| 8 |
Zhimei Huang, Mengxuan Zuo, Jia-yan Ni, Yangkui Gu, Tian-qi Zhang, Yiquan Jiang, Shuiqing Zhuo, Chao An, Jinhua Huang. <p>Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin grade: A Preliminary Study</p>. Cancer Management and Research 2020; : 1373 doi: 10.2147/CMAR.S234116
|
| 9 |
Hyo Jung Cho, Soon Sun Kim, So Young Kang, Min Jae Yang, Choong Kyun Noh, Jae Chul Hwang, Sun Gyo Lim, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Jin Hong Kim, Sung Won Cho, Jae Youn Cheong. A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status. Gut and Liver 2019; 13(5): 557 doi: 10.5009/gnl18444
|
| 10 |
Shun-Yu Kong, Jiao-Jiao Song, Yao-Qi Jin, Man-Jun Deng, Jing-Xin Yan. Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Acta Clinica Belgica 2023; 78(2): 171 doi: 10.1080/17843286.2022.2076791
|
| 11 |
Kazuo Asano, Ken Kageyama, Akira Yamamoto, Atsushi Jogo, Sawako Uchida-Kobayashi, Etsuji Sohgawa, Kazuki Murai, Norifumi Kawada, Yukio Miki. Transcatheter Arterial Chemoembolization for Treatment-Naive Hepatocellular Carcinoma Has Different Treatment Effects Depending on Central or Peripheral Tumor Location. Liver Cancer 2023; 12(6): 576 doi: 10.1159/000530441
|
| 12 |
Masashi Hirooka, Atsushi Hiraoka, Hironori Ochi, Yoshiyasu Kisaka, Kouji Joko, Kojiro Michitaka, Yoichi Hiasa. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma. American Journal of Roentgenology 2018; 210(4): 891 doi: 10.2214/AJR.17.18177
|
| 13 |
Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka, Takashi Niizeki, Tomotake Shirono, Akira Kajiwara, Yu Noda, Naoki Kamachi, Shusuke Okamura, Masahito Nakano, Ryoko Kuromatsu, Takumi Kawaguchi, Hironori Koga, Takuji Torimura. Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival. Oncology 2021; 99(12): 756 doi: 10.1159/000518612
|
| 14 |
Masatoshi Kudo. A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE. Liver Cancer 2019; 8(5): 299 doi: 10.1159/000502905
|
| 15 |
Masatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, Jian Zhou, Yi-Hsiang Huang, Shi-Ming Lin, Chung-Kwe Wang, Masafumi Ikeda, Stephen Lam Chan, Su Pin Choo, Shiro Miyayama, Ann Lii Cheng. A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements. Liver Cancer 2020; 9(3): 245 doi: 10.1159/000507370
|